Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By Amna Nawaz, Laura Santhanam, Dorothy Hastings
There’s no vaccine to prevent hepatitis C infections, which often go undetected for years – experts say the virus’ stealthy nature and inadequate access to testing mean that many more people likely have hepatitis C and don’t even know it.
By Laura Santhanam
New drugs can cure up to 95 percent of patients with hepatitis C, a virus that can be debilitating or deadly. And there’s been a 20 percent rise in new infections from 2015 to 2016 due to the opioid epidemic.
By Cat Wise
Most adults say they struggle with remembering to take their prescriptions. A nationwide study is testing a pill with an ingestible sensor that tracks medication adherence from inside the body.
Among pregnant women, the hepatitis C infection rate nearly doubled in five years, fueled primarily by injection drug use linked to the opioid crisis, and the medical community is increasingly concerned that mothers and infants may go undetected and untreated…
By PBS NewsHour
In our news wrap Friday, a massive cyberattack that infected computers with ransomware crippled major institutions and companies in scores of countries. Also, the Justice Department has issued a directive to federal prosecutors to seek tougher sentences for the vast…
By Lauran Neergaard, Associated Press
WASHINGTON — Some patients facing a years-long wait for a kidney transplant are jumping ahead in line thanks to a startling experiment: They're agreeing to an organ almost sure to infect them with hepatitis C.
By Stephen Fee, Mori Rothman
The Cherokee Nation, one of the largest Native American tribes, has become the first community in the U.S. to set a goal of eliminating hepatitis C from its population. Tribe officials plan to screen 300,000 members, whose prevalence of infection…
By Ricardo Alonso-Zaldivar, Associated Press
WASHINGTON — A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure.
Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures.
Support Provided By: